Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.0001
0 %
$ 175
Market Cap
0.0
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
501.71%
EBIT
Estimate
--572.05%
Net Income
Estimate
220.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Clever Leaves Holdings Inc.
CLVR has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CLVR
EBIT FORECAST
EBIT Forecast Chart CLVR
NET INCOME FORECAST
Net Income Chart CLVR